Fetal cells in women with skin ulcers
Treatments studied
Part of Heart & circulation, Skin clinical trials.
This study looks at fetal cells that stay in a woman's body after pregnancy to see if they play a role in chronic skin ulcers. It includes women who have had a baby and have a venous, diabetic, sickle cell, or mixed ulcer, as well as healthy women for comparison.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult woman
- You have been pregnant at some point in your life
- You have a skin ulcer caused by vein problems, diabetes, sickle cell disease, or a mix of these
- Or you are a healthy woman without skin ulcers and similar age to the patients
- You are willing to give blood and saliva samples
- You are not currently taking medicines that weaken your immune system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This trial tests if adding a special placenta-based wound covering to standard care helps heal diabetic foot ulcers and venous leg ulcers faster. It's for people with wounds that haven't healed after standard treatment for at least 4 weeks.
This study collects blood (and sometimes tissue samples) from people who may have vascular (blood vessel) problems and from certain pregnant participants. Researchers use the samples to better understand vascular disease and to help guide future research.
This study looks at fluid from chronic (non-healing) wounds to understand why they don't heal and how biofilms (bacteria that stick to wounds) affect healing. The goal is to find better ways to treat these wounds.
This trial tests a new cell treatment for diabetic foot ulcers by injecting special regulatory monocytes (OPM cells) to help heal wounds. It is for patients with mild to moderate ulcers that haven't healed for over a month.
This trial tests whether adding a special treatment (cellular acellular and matrix-like products) to standard wound care helps diabetic foot ulcers and venous leg ulcers heal faster. It may be an option if you have a diabetes-related foot ulcer that hasn't healed with standard care.
Hear when a new Venous Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.